Christian Heidbreder

Christian Heidbreder

Chief Scientific OfficeratIndivior Pharmaceuticals· In proxies 2023–2025

Pay in FY2025+67% from the year before · Indivior Pharmaceuticals stock +188.7% the same year

Christian Heidbreder was paid $4.2M in FY2025 (Dec), up 67%. Indivior Pharmaceuticals stock rose 188.7% that year.

Pay$100 in the stock at the end of FY23 → $235
Pay is from the Summary Compensation Table of each Indivior Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Indivior PharmaceuticalsPublic company · 3 yr
    • Chief Scientific Officer2023 – Present · 3 yrStock in role +57%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?